The new research from the Oldstone lab shows a single protein can make the difference between an infection clearing out of the body or persisting for life.
In a pair of related studies, scientists from the Martemyanov lab have identified several proteins that help regulate cells’ response to light—and the development of night blindness, a rare disease that abolishes the ability to see in dim light.
The new drug candidates, identified by the Torbett lab using a new screening method, act on a target unlikely to mutate.
“The long-term goal is to develop an entirely new and effective method for treating cocaine addiction,” says Thomas Bannister, assistant professor in the Department of Chemistry and associate scientific director in the Translational Research Institute at Scripps Florida.